NCT03477539
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
Clinical trial condition
Hemostatic Disorders
Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.
3,075 public trials
581 recruiting studies
Hemostatic Disorders trial results
NCT05064358
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- GSK Investigational Site West Palm Beach, Florida, United States
- GSK Investigational Site Kansas City, Missouri, United States
- GSK Investigational Site New York, United States
- GSK Investigational Site Chattanooga, Tennessee, United States
NCT04083534
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Regeneron Study Site Indianapolis, Indiana, United States
- Regeneron Study Site Ann Arbor, Michigan, United States
- Regeneron Study Site Rochester, Minnesota, United States
- Regeneron Study Site New York, United States
NCT00339963
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
- Locations
-
- National Cancer Institute (NCI), 9000 Rockville Pike Bethesda, Maryland, United States
NCT01231412
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +58 more
- Locations
-
- University of Colorado Denver, Colorado, United States
- Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
Completed
Ultra-low-dose Chest CT for HHT
NCT04874558
- Conditions
- Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +10 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Completed
A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma
NCT02316106
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Little Rock, Arkansas, United States
- Jacksonville, Florida, United States
- West Palm Beach, Florida, United States
- Atlanta, Georgia, United States
NCT01158807
- Conditions
- Arteriovenous Malformations, Brain Diseases, Cardiovascular Abnormalities, +19 more
- Locations
-
- Barrow Neurological Institute Phoenix, Arizona, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- David Geffen School of Medicine at University of California, Los Angeles Los Angeles, California, United States
- University of California, San Francisco San Francisco, California, United States
NCT01816971
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- Dana Farber Boston, Massachusetts, United States
- Washington University in St Louis St Louis, Missouri, United States
- Sarah Cannon Cancer Center Nashville, Tennessee, United States
NCT03777306
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States